4CE9
Interrogating HIV integrase for compounds that bind- a SAMPL challenge
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A, B (A, B) | INTEGRASE | polymer | 183 | 20044.7 | 2 | UniProt (Q76353) Pfam (PF00665) UniProt (by SIFTS) (P12497) | HUMAN IMMUNODEFICIENCY VIRUS 1 (HIV) | |
| 2 | C, D, H, I (A, B) | SULFATE ION | non-polymer | 96.1 | 4 | Chemie (SO4) | |||
| 3 | E, J (A, B) | ACETIC ACID | non-polymer | 60.1 | 2 | Chemie (ACY) | |||
| 4 | F, K (A, B) | GLYCEROL | non-polymer | 92.1 | 2 | Chemie (GOL) | |||
| 5 | G, L (A, B) | (2S)-2-(2-carboxyethyl)-6-{[{2-[(cyclohexylmethyl)carbamoyl]benzyl}(prop-2-en-1-yl)amino]methyl}-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid | non-polymer | 550.6 | 2 | Chemie (O3N) | |||
| 6 | M, N (A, B) | water | water | 18.0 | 96 | Chemie (HOH) |
Sequence modifications
A, B: 50 - 212 (UniProt: Q76353)
| PDB | External Database | Details |
|---|---|---|
| Met 30 | - | expression tag |
| Gly 31 | - | expression tag |
| Ser 32 | - | expression tag |
| Ser 33 | - | expression tag |
| His 34 | - | expression tag |
| His 35 | - | expression tag |
| His 36 | - | expression tag |
| His 37 | - | expression tag |
| His 38 | - | expression tag |
| His 39 | - | expression tag |
| Ser 40 | - | expression tag |
| Ser 41 | - | expression tag |
| Gly 42 | - | expression tag |
| Leu 43 | - | expression tag |
| Val 44 | - | expression tag |
| Pro 45 | - | expression tag |
| Arg 46 | - | expression tag |
| Gly 47 | - | expression tag |
| Ser 48 | - | expression tag |
| His 49 | - | expression tag |
| Ser 56 | Cys 56 | engineered mutation |
| Asp 139 | Phe 139 | engineered mutation |
| His 185 | Phe 185 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 2 |
| Total formula weight | 40089.3 | |
| Non-Polymers* | Number of molecules | 10 |
| Total formula weight | 1789.8 | |
| All* | Total formula weight | 41879.2 |






